Research Article, J Spine Neurosurg Vol: 3 Issue: 4
Evolution of Adverse Events on Ct-Scan after Use of Rhbmp-2 in Plif Surgery
Michielsen J1,2, Sys J3*, Rigaux A4, Bertrand C1 and Vanlaer L2 | |
1Department of Orthopaedics and Traumatology, Monica Hospital, Florent Pauwelslei 1,2100 Antwerp, Belgium | |
2Consultant spine surgeon, University Hospital of Antwerp, 2650 Antwerp, Belgium | |
3Department of Orthopaedics and Traumatology, Sint Basius Hospital, Kroonveldlaan 50, 9200 Dendermonde, Belgium | |
4Department of Radiology, Monica Hospital, Florent Pauwelslei 1, 2100 Antwerp, Belgiums | |
Corresponding author : Sys J Department of Orthopaedics and Traumatology, Sint Basius Hospital, Kroonveldlaan 50, 9200 Dendermonde, Belgium Tel: 32-38-996018; Fax: 32-52-201289 E-mail: dr.sys@telenet.be |
|
Received: January 30, 2014 Accepted: March 28, 2014 Published: April 02, 2014 | |
Citation: Michielsen J, Sys J, Rigaux A, Bertrand C, Vanlaer L (2014) DEvolution of Adverse Events on Ct-Scan after Use of Rhbmp-2 in Plif Surgery. J Spine Neurosurg 3:4 doi:10.4172/2325-9701.1000145 |
Abstract
Evolution of Adverse Events on Ct-Scan after Use of Rhbmp-2 in Plif Surgery
In this prospective nonrandomized trial, our objective was to assess the clinical and radiological effects of using rhBMP-2 and absorbable collagen carrier (inductOs™) in conjunction with PEEK PLIF cages (Telamon) for one-level instrumented fusions, after 2 years. Additional CT-scans were taken at 3 years.